Klaudia Maleki
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Klaudia Maleki has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Elke Weisshaar
Sektion Berufsdermatologie, Zentrum Hautklinik, Universitätsklinikum Heidelberg, Ruprecht-Karls Universität Heidelberg, Heidelberg, Deutschland
1 shared publication - Jutta Passlick-Deetjen
Department of Nephrology, University Hospital, Duesseldorf, Germany.
1 shared publication - Melanie Weiss
Department of Clinical Social Medicine, Occupational and Environmental Dermatology, Ruprecht-Karls University Heidelberg, Thibautstrasse 3, 69115, Heidelberg, Germany.
1 shared publication - Thomas Mettang
DKD Helios Klinik Wiesbaden, Aukammallee 33, 65191, Wiesbaden, Deutschland.
1 shared publication - Ulrich Tschulena
Fresenius Medical Care, Deutschland GmbH, 61352 Bad Homburg, Germany
1 shared publication
Latest Publications
- Open Access
- 4 November 2015
- Published by Springer Nature in BMC Nephrology
- Vol. 16 (1) , 1-8
Laboratory and dialysis characteristics in hemodialysis patients suffering from chronic itch - results from a representative cross-sectional study
A representative cross-sectional study showed that chronic itch (lasting for a minimum of 6 weeks) affects 25.2 % (point prevalence) of hemodialysis (HD) patients. Pathophysiology and etiology of chronic itch (CI) in HD are still unclear. We investigated 860 HD patients from a representative randomly selected cluster-sample considering the regional distributions of dialysis units in GermanyThe current analyses report comorbidities, laboratory values and dialysis characteristics of HD patients in relation to CI. Diabetes was the only comorbidity that was associated with the occurrence of itch but interestingly with less CI. Except for creatinine, phosphorus, and parathormone, there were no significant associations between the occurrence and characteristics of CI and any laboratory value. Kt/V was not associated with the presence of CI. Patients dialyzed with polyarylethersulfone-membrane showed significantly more CI in all prevalence estimates and those dialyzed with polysulfone-membrane were significantly less affected by CI. Long-term follow-up studies will show if the type of dialysis membrane influences the development of CI in HD patients. It is most likely that several factors e.g. elevated parathormone, origin of end stage renal disease (ESRD), type of dialysis membrane, and a neuropathic component all contribute to the occurrence of CI in HD patients. Future research should consider a multifactorial origin of itch in HD.
- 4 November 2015
- Published by Springer Nature in BMC Nephrology
- Vol. 16 (1) , 1-8
Open AccessLaboratory and dialysis characteristics in hemodialysis patients suffering from chronic itch - results from a representative cross-sectional study
A representative cross-sectional study showed that chronic itch (lasting for a minimum of 6 weeks) affects 25.2 % (point prevalence) of hemodialysis (HD) patients. Pathophysiology and etiology of chronic itch (CI) in HD are still unclear. We investigated 860 HD patients from a representative randomly selected cluster-sample considering the regional distributions of dialysis units in GermanyThe current analyses report comorbidities, laboratory values and dialysis characteristics of HD patients in relation to CI. Diabetes was the only comorbidity that was associated with the occurrence of itch but interestingly with less CI. Except for creatinine, phosphorus, and parathormone, there were no significant associations between the occurrence and characteristics of CI and any laboratory value. Kt/V was not associated with the presence of CI. Patients dialyzed with polyarylethersulfone-membrane showed significantly more CI in all prevalence estimates and those dialyzed with polysulfone-membrane were significantly less affected by CI. Long-term follow-up studies will show if the type of dialysis membrane influences the development of CI in HD patients. It is most likely that several factors e.g. elevated parathormone, origin of end stage renal disease (ESRD), type of dialysis membrane, and a neuropathic component all contribute to the occurrence of CI in HD patients. Future research should consider a multifactorial origin of itch in HD.